SCHEMBL4895965

SCHEMBL4895965

CCN(c1ccc(OCc2c(F)cccc2Cl)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TSHR P16473 1/20 0.45
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
ESR1 P03372 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
TP53 P04637 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905839 0.91 LMNA (0.45) LMNAALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL4905829 0.91 LMNA (0.53) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907053 0.90 LMNA (0.48) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4905972 0.86 LMNA (0.55) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4908772 0.84 LMNA (0.45) LMNAALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL4906802 0.84 POLB (0.44) LMNAALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL4905993 0.82 LMNA (0.56) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4903420 0.82 LMNA (0.57) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4904188 0.82 LMNA (0.53) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907030 0.82 LMNA (0.51) LMNAALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.